UBS Group’s Kairos Pharma, Ltd. KAPA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$6.71K	Buy	9,458 +6,666	+239%	+$4.73K	﹤0.01%	7744
2025 Q1	$2.61K	Sell	2,792 -8,053	-74%	-$7.54K	﹤0.01%	7984
2024 Q4	$16.5K	Buy	+10,845	New	+$16.5K	﹤0.01%	6768